Psychotic Disorders - Gambia | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$3.85m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.57%, resulting in a market volume of US$3.96m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$173.60 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Gambia is experiencing steady growth and development.

Customer preferences: Customers in Gambia are increasingly seeking effective treatments for psychotic disorders. They are looking for medications that can help manage symptoms such as hallucinations, delusions, and disorganized thinking. Customers also value medications that have minimal side effects and are affordable. Additionally, there is a growing demand for psychological therapies and support services to complement medication-based treatments.

Trends in the market: One of the main trends in the Psychotic Disorders market in Gambia is the increasing availability and accessibility of medications. Pharmaceutical companies are expanding their distribution networks and partnering with local healthcare providers to ensure that medications reach customers in remote areas. This trend is driven by the government's efforts to improve healthcare infrastructure and increase access to essential medications.Another trend is the integration of traditional healing practices with modern medical treatments. Many Gambians still rely on traditional healers for the treatment of psychotic disorders. As a result, there is a growing interest in combining traditional remedies with evidence-based treatments. This trend is supported by research showing that a holistic approach, which includes both traditional and modern therapies, can improve treatment outcomes.

Local special circumstances: Gambia has a relatively high prevalence of psychotic disorders compared to other countries in the region. This can be attributed to various factors, including poverty, limited access to healthcare, and cultural beliefs. The government has recognized the need to address these issues and has implemented initiatives to improve mental health services. For example, they have increased funding for mental health programs and established community-based support services.

Underlying macroeconomic factors: The economic growth in Gambia has contributed to the development of the Psychotic Disorders market. As the economy improves, individuals have more disposable income to spend on healthcare, including medications and therapies for psychotic disorders. Additionally, the government's investment in healthcare infrastructure has created job opportunities in the healthcare sector, leading to increased access to mental health services.In conclusion, the Psychotic Disorders market in Gambia is growing and evolving to meet the needs of customers. The increasing availability of medications, integration of traditional healing practices, and government initiatives to improve mental health services are driving the market's development. The high prevalence of psychotic disorders in Gambia and the country's improving economy are also important factors contributing to the market's growth.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.